Skip to main content

Animations

MJFF Publications

5221 - 5230 of 8819 Results
Title
Year
  • Year
  • 2017
  • 2020
  • 2017
  • 2016
  • 2019
  • 2006
  • 2023
  • 2018
  • 2014
  • 2016
  • Summary Details
    OPEN
    Title: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's disease
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23547
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Development and validation of a sensitive HPLC-HESI-MS/MS method for quantitative determination of bitopertin in rat and marmoset plasma
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.12688/mniopenres.12850.1
    Citation Count: 2
  • Summary Details
    OPEN
    Title: MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.020
    Citation Count: 51
  • Summary Details
    RESTRICTED
    Title: Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aad8858
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.09.004
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Bridging a mechanistic gap from diet to synapses
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2309992120
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.012
    Citation Count: 45
  • Summary Details
    OPEN
    Title: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.03.004
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26483
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.